Frequently asked questions to the 2023 obesity medicine association position statement on compounded peptides: A call for action.
2023年肥胖醫學協會對於合成肽的立場聲明常見問題:行動的呼籲。
Obes Pillars 2024-09-04
Approved Anti-Obesity Medications in 2022 KSSO Guidelines and the Promise of Phase 3 Clinical Trials: Anti-Obesity Drugs in the Sky and on the Horizon.
2022年KSSO指南中已批准的抗肥胖藥物及第三期臨床試驗的前景:天空中和地平線上的抗肥胖藥物。
J Obes Metab Syndr 2023-07-10
An overview of therapeutic options of obesity management in India: the Integrated Diabetes and Endocrinology Academy (IDEA) 2023 Congress update.
印度肥胖管理治療選項概觀:整合糖尿病與內分泌學學會(IDEA)2023年大會更新。
Expert Rev Clin Pharmacol 2024-05-01
Examining the Potential Applicability of Orexigenic and Anorexigenic Peptides in Veterinary Medicine for the Management of Obesity in Companion Animals.
探討食慾促進和食慾抑制肽在獸醫學中對於管理伴侶動物肥胖的潛在應用性。
Curr Issues Mol Biol 2024-07-26